Crossref

1. A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models

- Jules Zhang-Yin

- Claire Provost

- Géraldine Cancel-Tassin

- Timofei Rusu

- Mallaurie Penent

- Camelia Radulescu

- Eva Comperat

- Olivier Cussenot

- Françoise Montravers

- Raphaële Renard-Penna

- Jean-Noël Talbot

- Aurélie Prignon

2. Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer

- Liang Kee Goh

- Natalia Liem

- Aadhitthya Vijayaraghavan

- Gengbo Chen

- Pei Li Lim

- Kae-Jack Tay

- Michelle Chang

- John Soon Wah Low

- Adita Joshi

- Hong Hong Huang

- Emarene Kalaw

- Puay Hoon Tan

- Wen-Son Hsieh

- Wei Peng Yong

- Joshi Alumkal

- Hong Gee Sim

- Jörg D. Hoheisel

3. Imaging and Management of Prostate Cancer

- Devaki Shilpa Sudha Surasi

- Brian Chapin

- Chad Tang

- Gregory Ravizzini

- Tharakeswara Kumar Bathala

4. A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer

- Franklyn De Silva

- Jane Alcorn

5. Molecular imaging for prostate cancer: Performance analysis of 68Ga-PSMA PET/CT versus choline PET/CT

- L. Michaud

- K.A. Touijer

6. The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms

- Robyn Meech

- Dong Gui Hu

- Ross A. McKinnon

- Siti Nurul Mubarokah

- Alex Z. Haines

- Pramod C. Nair

- Andrew Rowland

- Peter I. Mackenzie

7. Non-canonical androgen signaling pathways and implications in prostate cancer

- Versha Dahiya

- Gargi Bagchi

8. Targeting SMAD3 for inhibiting prostate cancer metastasis

- Qing Xia

- Chengjiang Li

- Pingda Bian

- Jue Wang

- Shuai Dong

9. Molecular characterization of an MLL1 fusion and its role in chromosomal instability

- Sreejit Parameswaran

- Frederick S. Vizeacoumar

- Kalpana Kalyanasundaram Bhanumathy

- Fujun Qin

- Md. Fahmid Islam

- Behzad M. Toosi

- Chelsea E. Cunningham

- Darrell D. Mousseau

- Maruti C. Uppalapati

- Peter C. Stirling

- Yuliang Wu

- Keith Bonham

- Andrew Freywald

- Hui Li

- Franco J. Vizeacoumar

10. Nano-based Herbal Medicine: A New Candidate for Prostate Cancer Treatment?

- Tayebe Pouryousefi-koodehi

- Mohammad Saeed Kahrizi

- Hossein Roghani-Shahraki

- Fatemeh Rezaei-Tazangi

- Reza Arefnezhad

- Hossein Motedayyen

11. The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG

- Johana A. Luna‐Coronell

- Klemens Vierlinger

- Magdalena Gamperl

- Johann Hofbauer

- Ingrid Berger

- Andreas Weinhäusel

12. Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk

- Dong Gui Hu

- Peter I. Mackenzie

- Ross A. McKinnon

- Robyn Meech

13. A Radiogenomic Approach for Decoding Molecular Mechanisms Underlying Tumor Progression in Prostate Cancer

- Sarah Fischer

- Mohamed Tahoun

- Bastian Klaan

- Kolja M. Thierfelder

- Marc-André Weber

- Bernd J. Krause

- Oliver Hakenberg

- Georg Fuellen

- Mohamed Hamed

14. Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities

- Rahaba Marima

- Rodney Hull

- Mandisa Mbeje

- Thulo Molefi

- Kgomotso Mathabe

- Abdulrahman M. Elbagory

- Demetra Demetriou

- Zodwa Dlamini

15. Toma de imágenes molecular del cáncer de próstata: análisis de rendimiento de 68Ga-PSMA PET/TC frente a PET/TC colina

- L. Michaud

- K.A. Touijer

16. Prostate cancer and pollution: Dangerous connections

- Sébastien Magnifico

- Charlotte Hinault-Boyer

- Frédéric Bost

- Nicolas Chevalier

17. Biopolymer and Biomaterial Conjugated Iron Oxide Nanomaterials as Prostate Cancer Theranostic Agents: A Comprehensive Review

- Md. Abu Rayhan

- Md. Sakib Hossen

- Mahruba Sultana Niloy

- Mozammel Haque Bhuiyan

- Sudip Paul

- Md. Salman Shakil

18. Network-based approach reveals Y chromosome influences prostate cancer susceptibility

- Pegah Khosravi

- Vahid H. Gazestani

- Yazdan Asgari

- Brian Law

- Mehdi Sadeghi

- Bahram Goliaei

19. Intrarectal Lidocaine-Diltiazem-Meperidine Gel for Transrectal Ultrasound Guided Prostate Biopsy

- Farsad Imani

- Yasaman Moghaddam

- Reza Shariat Moharari

- Farhad Etezadi

- Mohammad Reza Khajavi

- Seyed Reza Hosseini

20. The Somatic Mutation Landscape of UDP-Glycosyltransferase (UGT) Genes in Human Cancers

- Dong Gui Hu

- Shashikanth Marri

- Julie-Ann Hulin

- Ross A. McKinnon

- Peter I. Mackenzie

- Robyn Meech

21. Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1–Mediated Immune Evasion in Prostate Cancer

- Hailong Ruan

- Lin Bao

- Zhen Tao

- Ke Chen

22. Characterizing high-risk SPOP mutations in prostate cancer: Insights from computational analysis and protein-ligand docking

- Memona Aslam

- Aman Ullah

- Maqsood Ahmad

- Ali Umar

- Misbah Ullah Khan

- Muhammad Zia Ahmad

- Muhammad Saleem Khan

23. CURRENT PERSPECTIVES ON APPLICATIONS OF NANOPARTICLES FOR CANCER MANAGEMENT

- ROHIT R. BHOSALE

- BHAGYESH U. JANUGADE

- DHANASHRI D. CHAVAN

- VANDANA M. THORAT

24. Iron Oxide Nanoparticles for Visualization of Prostate Cancer in MRI

- Avan Kader

- Jan O. Kaufmann

- Dilyana B. Mangarova

- Jana Moeckel

- Julia Brangsch

- Lisa C. Adams

- Jing Zhao

- Carolin Reimann

- Jessica Saatz

- Heike Traub

- Rebecca Buchholz

- Uwe Karst

- Bernd Hamm

- Marcus R. Makowski

25.

26.

27. Functional role and tobacco smoking effects on methylation ofCYP1A1gene in prostate cancer

- Yozo Mitsui

- Inik Chang

- Taku Kato

- Yutaka Hashimoto

- Soichiro Yamamura

- Shinichiro Fukuhara

- Darryn K. Wong

- Marisa Shiina

- Mitsuho Imai-Sumida

- Shahana Majid

- Sharanjot Saini

- Hiroaki Shiina

- Koichi Nakajima

- Guoren Deng

- Rajvir Dahiya

- Yuichiro Tanaka

28. Unraveling the therapeutic potential of GANT61/Dactolisib combination as a novel prostate cancer modality

- Mohamed Youssef

- Nermine Moussa

- Maged W. Helmy

- Medhat Haroun

29. The Impact of Metabolic Syndrome and Type 2 Diabetes Mellitus on Prostate Cancer

- André P. Sousa

- Raquel Costa

- Marco G. Alves

- Raquel Soares

- Pilar Baylina

- Rúben Fernandes

30. Retracted: Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch‐1 signaling pathway

- Jingzhe Yang

- Chengli Wang

- Zhijie Zhang

- Xiaojun Chen

- Yusen Jia

- Bin Wang

- Tao Kong

31. Técnicas de imagen molecular en el cáncer de próstata: revisión de radiofármacos, modalidades y evidencia actual

- J.M. Quesada-Olarte

- M.E. Allaf

- M. Alvarez-Maestro

- L. Martínez-Piñeiro

32. Remodeling of androgen metabolism network mediated by UGT2B: a new perspective on treatment resistance in prostate cancer

- YuanYuan Wang

- Chenxi Tu

- Hao Qin

- Yingying Ma

- Yukai Yang

- Yinhua Xiong

- Liang Peng

- Lin Zhang

33. Positron emission tomography computed tomography in the diagnosis of prostate cancer

- Rashmi Umesh Angadi

34. Molecular imaging of prostate cancer: Review of imaging agents, modalities, and current status

- J.M. Quesada-Olarte

- M.E. Allaf

- M. Alvarez-Maestro

- L. Martínez-Piñeiroa

35. Inhibition of prostatic cancer growth by ginsenoside Rh2

- Qingchuan Zhang

- Bin Hong

- Songhua Wu

- Tianli Niu

36. TRPM4 regulates Akt/GSK3‐β activity and enhances β‐catenin signaling and cell proliferation in prostate cancer cells

- Alfredo I. Sagredo

- Eduardo A. Sagredo

- Claudio Cappelli

- Pablo Báez

- Rodrigo E. Andaur

- Constanza Blanco

- Julio C. Tapia

- César Echeverría

- Oscar Cerda

- Andrés Stutzin

- Felipe Simon

- Katherine Marcelain

- Ricardo Armisén

37. Synthesis and Preclinical Evaluation of [18F]SiFA-PSMA Inhibitors in a Prostate Cancer Model

- Justin J. Bailey

- Melinda Wuest

- Michael Wagner

- Atul Bhardwaj

- Carmen Wängler

- Bjoern Wängler

- John F. Valliant

- Ralf Schirrmacher

- Frank Wuest

38. Human Prostate Cancer Hallmarks Map

- Dipamoy Datta

- Md. Aftabuddin

- Dinesh Kumar Gupta

- Sanghamitra Raha

- Prosenjit Sen

39. Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling

- Tao Wang

- Wen Song

- Yuan Chen

- Ruibao Chen

- Zhuo Liu

- Licheng Wu

- Mingchao Li

- Jun Yang

- Liang Wang

- Jihong Liu

- Zhangqun Ye

- Chenguang Wang

- Ke Chen

40. The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer

- Ismail Selvi

- Halil Basar

- Numan Baydilli

- Koza Murat

- Ozlem Kaymaz

41. Chromatin Remodeler Mutations in Human Cancers: Epigenetic Implications

- Katherine A Skulte

- Lisa Phan

- Susan J Clark

- Phillippa C Taberlay

42.

43. Translationally Controlled Tumor Protein in Prostatic Adenocarcinoma: Correlation with Tumor Grading and Treatment-Related Changes

- Bruno Jim Rocca

- Alessandro Ginori

- Aurora Barone

- Calogera Calandra

- Filippo Crivelli

- Giulia De Falco

- Sara Gazaneo

- Sergio Tripodi

- Gabriele Cevenini

- Maria Teresa del Vecchio

- Maria Raffaella Ambrosio

- Piero Tosi

44.

45. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer

- Chuigong Yu

- Guojun Wu

- Ruixiao Li

- Lei Gao

- Fan Yang

- Yi Zhao

- Jian Zhang

- Rui Zhang

- Jing Zhang

- Libo Yao

- Jianlin Yuan

- Xia Li

46. Recent Advances in the Development and Utilization of Nanoparticles for the Management of Malignant Solid Tumors

- Dhanashri D Chavan

- Rohit R Bhosale

- Vandana M Thorat

- Amol S Shete

- Sarika J Patil

- Devkumar D Tiwari

47. A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line

- Kamila Domińska

- Tomasz Ochędalski

- Karolina Kowalska

- Zuzanna E. Matysiak-Burzyńska

- Elżbieta Płuciennik

- Agnieszka W. Piastowska-Ciesielska

48. The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?

- Felice Crocetto

- Mariarosaria Boccellino

- Biagio Barone

- Erika Di Zazzo

- Antonella Sciarra

- Giovanni Galasso

- Giuliana Settembre

- Lucio Quagliuolo

- Ciro Imbimbo

- Silvia Boffo

- Italo Francesco Angelillo

- Marina Di Domenico

49. Molecular MR Imaging of Prostate Cancer

- Avan Kader

- Julia Brangsch

- Jan O. Kaufmann

- Jing Zhao

- Dilyana B. Mangarova

- Jana Moeckel

- Lisa C. Adams

- Ingolf Sack

- Matthias Taupitz

- Bernd Hamm

- Marcus R. Makowski

50. The Prognostic and Therapeutic Potential of Fragile X Mental Retardation 1 (FMR1) Gene Expression in Prostate Adenocarcinoma: Insights into Survival Outcomes and Oncogenic Pathway Modulation

- Salem Baldi

- Bushra Amer

- Fawze Alnadari

- Maged AL-Mogahed

- Yaqin Gao

- Yaser Gamallat

51. Hormone resistance and neuroendocrine differentiation due to accumulation of genetic lesions during clonal evolution of prostate cancer

- D. S. Mikhaylenko

- G. D. Efremov

- A. V. Sivkov

- D. V. Zaletaev

52. The Noninvasive Detection of RARβ2 Promoter Methylation for the Diagnosis of Prostate Cancer

- Tong Zhang

- Lei Zhang

- Qinggong Yuan

- Xiangling Wang

- Yi Zhang

- Jinhua Wang

- Yanping Zhang

53. Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies

- Zachary S. Dovey

- Sujit S. Nair

- Dimple Chakravarty

- Ashutosh K. Tewari

54. Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer

- Giorgia Urbinati

- Hafiz Muhammad Ali

- Quentin Rousseau

- Hubert Chapuis

- Didier Desmaële

- Patrick Couvreur

- Liliane Massaad-Massade

- Natasha Kyprianou

55.

56. Discovery of Novel KuE PSMA PET Tracers through Structure Fine-Tuning and Direct Photocatalyzed 18F-Deoxyfluorination

- Yueqi Wang

- Mingxing Hu

- Junjie Wu

- Lili Pan

- Huijun Zhou

- Li Li

- Weihong Kuang

- Yongmei Xie

- Wei Chen

57. Molecular Imaging of Prostate Cancer

- Andreas G. Wibmer

- Irene A. Burger

- Evis Sala

- Hedvig Hricak

- Wolfgang A. Weber

- Hebert Alberto Vargas

58. SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells

- Carolina M Vicente

- Marcelo A Lima

- Helena B Nader

- Leny Toma